← Eichor
Condition: Adenocarcinoma Of The Rectum Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Adenocarcinoma Of The Rectum

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07448142A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05672524Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
Phase 1 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT04703101MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer
Phase 1 · 1 location(s) · Medical College of Wisconsin · NCT04808323Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT06834126The Efficacy and Safety of Short-course Radiation Combined With Adebrelimab and CAPEOX Neo-adjuvant Therapy for Organ-re
Phase 2 · 1 location(s) · Sir Run Run Shaw Hospital · NCT06266832Family Communications After Genetic Testing
NA · 276 location(s) · Alliance for Clinical Trials in Oncology · NCT07143487PRODIGE 90 - (FFCD 2204) Neoadjuvant Dostarlimab with Short Course Radiotherapy in a Watch-and-wait Strategy for Microsa
Phase 3 · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT06762405The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
Phase N/A · 1 location(s) · Case Comprehensive Cancer Center · NCT04624555FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT06780787A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-108
Phase 3 · 217 location(s) · Merck Sharp & Dohme LLC · NCT06997497ProLARS Trial: Prospective Longitudinal Follow-up of Low Anterior Resection Syndrome (LARS) and COREFO Score After Rectu
NA · 1 location(s) · University Hospital, Antwerp · NCT07339904Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Tislelizumab, Liposomal Irinotecan, and Capec
Phase 2 · 2 location(s) · Affiliated Cancer Hospital of Shantou University Medical Col · NCT07104604A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malign
Phase 1/Phase 2 · 13 location(s) · GV20 Therapeutics · NCT05669430Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
Phase N/A · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT04668872Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer
Phase 2 · 1 location(s) · Zhejiang University · NCT05731726Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · 485 location(s) · NRG Oncology · NCT05080673Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomi
Phase 3 · 1 location(s) · Shandong Cancer Hospital and Institute · NCT06850090Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma
Phase 2/Phase 3 · 30 location(s) · Institut du Cancer de Montpellier - Val d'Aurelle · NCT04749108ADAR1 Expression Level in Rectal Cancer
Phase N/A · 1 location(s) · Necmettin Erbakan University · NCT07108348Nordic ORgan Preservation Pilot Approach Nonrandomised Single-Arm Trial for Non-Operative Management of Rectal Cancer
NA · 13 location(s) · Tampere University Hospital · NCT06328361Dose Escalated Radiotherapy for Rectal Cancers Using MR-guided Radiotherapy
NA · 1 location(s) · Royal Marsden NHS Foundation Trust · NCT06854679Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma
Phase 3 · 1 location(s) · Sir Run Run Shaw Hospital · NCT05752136Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
EARLY_Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03594630Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001
Phase 2 · 3 location(s) · University of Nebraska · NCT05254327PET-imaging of Two Vartumabs in Patients With Solid Tumors
EARLY_Phase 1 · 1 location(s) · Var2 Pharmaceuticals · NCT06645808Organ Preservation in Rectal Cancer: Contact X-ray Brachytherapy vs Extending the Waiting Interval and Local Excision
NA · 7 location(s) · The Netherlands Cancer Institute · NCT05772923Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative I
Phase 2 · 4 location(s) · Emory University · NCT07405476Exercise for Improving Long-course Chemoradiotherapy Efficacy in People With Locally Advanced Rectal Cancer
EARLY_Phase 1 · 1 location(s) · University of Hull · NCT06276686Beyond TME Origins
NA · 4 location(s) · Imperial College London · NCT02292641
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.